Latest news with #salesteam
Travel Weekly
4 days ago
- Business
- Travel Weekly
Koreen McNutt joins Virgin Voyages' sales team
Virgin Voyages has added to its sales executive team, aiming to bolster support of travel advisors. Koreen McNutt Koreen McNutt is the new vice president of agency and business development, and Kristy Woolums is now senior director of national strategic accounts for North America. McNutt was most recently with MSC Cruises, where she was commercial sales officer and senior vice president of sales and trade engagement. She previously worked at Expedia Group. Stephen Hopkins Additionally, the vice president of growth and international sales and marketing, Stephen Hopkins, will now also handle sales acceleration. All three will work under chief marketing officer Nathan Rosenberg as part of what Virgin describes as a newly unified commercial team. Rosenberg took over the duties of John Diorio, who resigned as vice president of North American sales earlier this month. Kristy Woolums "By working in better coordination across our brand story, marketing strategy and sales execution, we reduce mixed messages and disconnected experiences for our First Mates," Rosenberg said. (First Mates are travel advisors.) "This creates integrated strategies that make it easier for them to sell Virgin Voyages successfully." Woolums was promoted from within Virgin Voyages and will now work exclusively on high-value strategic partnerships. CLARIFICATION: This report was edited to removed the implication that McNutt left MSC Cruises for Virgin Voyages.
Travel Weekly
5 days ago
- Business
- Travel Weekly
Sales executive departs MSC Cruises for Virgin Voyages
Virgin Voyages has added to its sales executive team, aiming to bolster support of travel advisors. Koreen McNutt Koreen McNutt is the new vice president of agency and business development, and Kristy Woolums is now senior director of national strategic accounts for North America. McNutt joins Virgin Voyages from MSC Cruises, where she was commercial sales officer and senior vice president of sales and trade engagement. She previously worked at Expedia Group. Stephen Hopkins Additionally, the vice president of growth and international sales and marketing, Stephen Hopkins, will now also handle sales acceleration. All three will work under chief marketing officer Nathan Rosenberg as part of what Virgin describes as a newly unified commercial team. Rosenberg took over the duties of John Diorio, who resigned as vice president of North American sales earlier this month. Kristy Woolums "By working in better coordination across our brand story, marketing strategy and sales execution, we reduce mixed messages and disconnected experiences for our First Mates," Rosenberg said. (First Mates are travel advisors.) "This creates integrated strategies that make it easier for them to sell Virgin Voyages successfully." Woolums was promoted from within Virgin Voyages and will now work exclusively on high-value strategic partnerships.
Yahoo
19-05-2025
- Business
- Yahoo
Duroply Industries Ltd (BOM:516003) (Q4 2025) Earnings Call Highlights: Record Revenue and ...
Release Date: May 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Duroply Industries Ltd (BOM:516003) achieved a significant milestone by crossing the 100 crore quarterly revenue benchmark for the first time, marking a 25.9% growth over the same period last year. The company's gross margins improved to 34.9% this quarter, up from 33.1% in the same quarter last year, due to better raw material costs and a favorable product mix. Revenue from contract manufacturing saw a substantial increase, with a 36% year-on-year growth and a 32% quarter-on-quarter growth. The EBITDA margin for the quarter increased significantly, standing at 5.4% of sales compared to 1.4% in the same quarter last year. Duroply Industries Ltd (BOM:516003) has made strategic investments in expanding its sales team and marketing efforts, which have started to yield positive results in terms of revenue growth. The company's debtor days increased to 47 days from 39 days in the previous year, indicating a slower collection period. Inventory days rose to 165 days compared to 149 days in the previous year, which could tie up capital and affect cash flow. Despite improvements, the company's EBITDA margin is still lower than some peers, which have margins in the 9-10% range. The company faces challenges from raw material cost pressures, although some easing is expected later in the year. Duroply Industries Ltd (BOM:516003) operates in a highly competitive market with a significant unorganized sector, which still holds approximately 75% market share. Warning! GuruFocus has detected 6 Warning Signs with BOM:516003. Q: What percentage of sales is allocated to advertising expenses, and which regions are seeing aggressive advertising efforts? A: The advertising expense for this year stood at 3.8% of sales, which includes brand promotion activities and influencer programs. Over 60% of revenue comes from North India, where aggressive investments continue. Additionally, selected pockets in South and West India are targeted for aggressive marketing and sales force development. (Answered by CEO) Q: How long will it take for new markets to mature, and are there any new product lines introduced? A: It will take 2 to 3 years for new markets to mature and become significant players. The company introduced 10 ft plywood and fluted panel veneer sheets but is not planning major product line expansions currently. The focus remains on growing revenue from existing product lines. (Answered by CEO) Q: What is the revenue mix between B2B and retail, and how does it affect margins and working capital? A: 95% of revenue comes from B2B, primarily through dealers to home buyers and contractors. Margins are similar across segments, with a focus on the home buyer retail segment. The debtor days increased due to extraordinary sales growth, typically around 40 to 42 days. Inventory days are higher due to strategic investments in finished goods inventory. (Answered by CEO) Q: What is the outlook on raw material costs, and how have gross margins improved? A: Raw material costs are expected to soften in the latter half of the year due to increased focus on sustainable plantations. Gross margins improved due to a better product mix, slight easing of timber prices, and efficiencies in plant and procurement processes. (Answered by CEO) Q: How does the company plan to address the competitive intensity in the plywood industry? A: The main barrier to entry is securing shelf space with channel partners. The company focuses on maintaining strong relationships with quality channel partners, which is crucial for scaling beyond a certain size. The industry has seen large players struggle to enter or exit due to this challenge. (Answered by CEO) For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14-05-2025
- Business
- Yahoo
Electromed Inc (ELMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Revenue: $15.7 million, a 13.1% increase year-over-year. Operating Income: $2.1 million, a 16.2% increase year-over-year. Net Income: $1.9 million, a 26.7% increase year-over-year, or $0.21 per diluted share. Direct Homecare Revenue: $14.1 million, a 14.8% increase year-over-year. Gross Profit: $12.2 million, 78.0% of net revenues, up from 74.8%. SG&A Expenses: $9.8 million, a 17.2% increase year-over-year. Pretax Income: $2.3 million. Cash Position: $15.2 million as of March 31, 2025. Share Repurchase: $1.4 million worth of stock repurchased in Q3. Sales Representatives: 55 reps, up from 51 in the prior year. Warning! GuruFocus has detected 2 Warning Sign with ELMD. Release Date: May 13, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Electromed Inc (ELMD) reported its 10th consecutive quarter of year-over-year revenue and net income growth, with a 13.1% increase in revenue to $15.7 million. The company achieved a 26.7% increase in net income year-over-year, reaching $1.9 million or $0.21 per diluted share. Electromed Inc (ELMD) has expanded its team of direct sales reps to 55, up from 51 in the prior year, contributing to increased sales and market reach. The company launched a successful Veterans Administration direct-to-consumer outreach program, generating significant engagement with 1,200 clicks and 1,100 page views. Electromed Inc (ELMD) maintains a strong cash position with $15.2 million in cash and no debt, allowing for strategic investments and a share repurchase program of up to $5 million. SG&A expenses increased by 17.2% to $9.8 million, primarily due to higher salaries and incentive compensation, which could impact future profitability. There was a 7.5% decline in hospital revenue and a 41.5% decline in other revenue, indicating potential challenges in non-homecare business segments. The cash balance decreased by $0.8 million for the nine months ended March 31, 2025, compared to an increase in the prior year, partly due to share repurchases. Electromed Inc (ELMD) faces potential risks from the current tariff situation, which could affect its supply chain despite being primarily U.S.-based. The company is in the process of implementing a new CRM system, which could temporarily reduce productivity during the transition period. Q: Can you comment on your approach to adding sales reps and your plans for future expansion? A: James Cunniff, President and CEO, explained that Electromed is taking a deliberate approach to adding sales reps to avoid disengagement and ensure effective territory management. They are already hiring for the next fiscal year and plan to add another sales representative for their hospital business, seeing growth opportunities there. Q: How do you feel about the $900,000 to $1 million per rep target range? A: Brad Nagel, CFO, noted that Electromed has exceeded this target in two out of three quarters this year. They aim to maintain a strong revenue per rep and may revise the target as they enter the new fiscal year. Q: What is your outlook on the reimbursement environment given current volatility? A: James Cunniff stated that Electromed has been insulated from reimbursement volatility and has seen positive developments with a new leader in payer relations opening more opportunities for coverage. They do not currently see reimbursement as a risk but will continue to monitor it closely. Q: Can you provide an update on the implementation of your new CRM system? A: James Cunniff mentioned that the CRM system is set to launch at the beginning of the next fiscal year. The team is preparing with user acceptance training and aims to integrate several disparate systems, enhancing overall efficiency. Q: Have you seen measurable impacts from the Triple Down on Bronchiectasis campaign? A: James Cunniff reported over 27,000 views on the campaign's landing page. While it's challenging to directly correlate this to new prescriptions, the campaign has contributed to increased market awareness and referral growth, which is reflected in revenue growth. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
